🔬 Research Grade Peptides • 99%+ Purity Tested • Bitcoin Accepted
GLP-1 Receptor Agonist

Semaglutide

What does "GLP-1 Receptor Agonist" mean?

GLP-1 (Glucagon-Like Peptide-1) is a hormone your gut naturally releases after eating. A "receptor agonist" is a compound that activates the same receptors as the natural hormone. So a GLP-1 Receptor Agonist mimics the effects of this natural gut hormone.

🎓

Explained Simply

Imagine your body has a "full" signal that tells your brain to stop eating. Semaglutide is like turning up the volume on that signal. It also helps your body use sugar better by telling your pancreas to release insulin when blood sugar is high. Think of it as a helper that makes your body's natural systems work more effectively.

How It Works

Semaglutide binds to and activates the GLP-1 receptor, which is expressed in pancreatic beta cells, the gastrointestinal tract, and the central nervous system. This activation leads to glucose-dependent insulin secretion, reduced glucagon release, and delayed gastric emptying.

Research by Sex

👨

Effects in Men

  • •Studies show comparable efficacy in glucose control between men and women
  • •Men may experience slightly faster initial response due to higher baseline metabolic rate
  • •Research indicates potential benefits for testosterone levels in men with metabolic dysfunction
  • •Body composition changes typically show greater reduction in visceral fat
  • •Some studies suggest improved cardiovascular risk markers
👩

Effects in Women

  • •Women may experience more pronounced appetite suppression effects
  • •Hormonal fluctuations during menstrual cycle may affect response variability
  • •Research shows potential interactions with estrogen-mediated metabolic pathways
  • •Studies indicate benefits may be particularly notable in post-menopausal women
  • •Fertility considerations: research ongoing regarding effects on reproductive hormones

Key Terms Explained

GLP-1

Glucagon-Like Peptide-1, a hormone produced in the gut that regulates blood sugar and appetite

Receptor Agonist

A compound that binds to and activates a cellular receptor, mimicking the natural substance

Insulin

A hormone that helps cells absorb sugar from the blood for energy

Research Areas

  • •Glucose metabolism and insulin sensitivity
  • •Appetite regulation and satiety signaling
  • •Cardiovascular outcomes in metabolic research
  • •Neuroprotective effects and cognitive function
  • •Beta cell preservation and function

Published Studies

Laboratory Protocols

Storage

Store lyophilized peptide at -20°C. Reconstituted solution should be stored at 2-8°C and used within 30 days.

Reconstitution

Reconstitute with bacteriostatic water or sterile water. Add diluent slowly down the side of the vial.

Quick Facts

Category

GLP-1 Receptor Agonist

Molecular Weight

4113.64 g/mol

Half-Life

~7 days

Amino Acid Sequence

His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(palmitoyl-Glu-OEG-OEG)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly

Research Grade Semaglutide

Browse our selection of Semaglutide from verified vendors.

View Products

Grokipedia

Quick Reference

View detailed research data including key facts, mechanism of action, and safety profile.

Disclaimer: This information is provided for educational purposes only. These products are intended for laboratory research use only. Not for human consumption.

Grokipedia

Quick Reference

Semaglutide

Semaglutide is a GLP-1 receptor agonist with 94% sequence homology to native human GLP-1. Strategic amino acid substitutions and a C18 fatty acid chain provide DPP-4 resistance and extended half-life through albumin binding.

Key Facts

  • •Molecular weight: 4113.64 g/mol
  • •Half-life: approximately 7 days
  • •94% homology to native GLP-1
  • •Albumin binding extends duration
  • •Once-weekly administration

Mechanism of Action

Binds GLP-1 receptors in pancreatic beta cells, GI tract, and CNS. Leads to glucose-dependent insulin secretion, reduced glucagon release, and delayed gastric emptying. Affects appetite regulation through central mechanisms.

Research Applications

  • Glucose metabolism research
  • Appetite and satiety signaling studies
  • Cardiovascular outcomes research
  • Beta cell function studies

Safety Profile

FDA-approved for certain indications. GI effects most common. Contraindicated with MEN2 or medullary thyroid cancer history. Research applications should follow appropriate protocols.

Disclaimer: This information is for educational and research purposes only. Products are intended for laboratory research use only. Not for human consumption.